BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2025 Earnings Call Transcript
Operator: Good day, and welcome to the BioCryst First Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode.
Posts Tagged ‘NASDAQ:BCRX’
10 Best Small-Cap Stocks to Buy Now
The S&P 500 index has reached its all-time highs, achieving returns of over 20% for two second consecutive years post-COVID.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2024 Earnings Call Transcript
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2024 Earnings Call Transcript February 24, 2025BioCryst Pharmaceuticals, Inc. misses on earnings expectations.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q3 2024 Earnings Call Transcript
Operator: Good day and Welcome to the BioCryst Third Quarter 2024 Earnings Call. All participants will be in listen-only mode.
Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks
The start of October has seen another wild swing for markets.
10 Best Biotech Stocks To Buy Under $20
The biotechnology industry is experiencing rapid growth, driven by increasing demand for innovative treatments, technological advancements, and government support.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q2 2024 Earnings Call Transcript
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q2 2024 Earnings Call Transcript August 5, 2024BioCryst Pharmaceuticals, Inc. beats earnings expectations.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript
BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.31 EPS, expectations were $-0.23.
12 Best Depressed Stocks To Buy in 2024
In this article, we will take a detailed look at the 12 Best Depressed Stocks To Buy in 2024. For a quick overview of the 5 such stocks, read our article 5 Best Depressed...
13 Best Biotech Stocks To Buy Under $20
In this article, we're going to take a look at 13 best biotech stocks to buy under $20.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2023 Earnings Call Transcript
BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.28 EPS, expectations were $-0.24. BioCryst Pharmaceuticals, Inc.
5 Best Medical Stocks to Buy Under $10
In this article, we will take a look at the 5 best medical stocks to buy under $10.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q3 2023 Earnings Call Transcript
Operator: Good morning and welcome to the BioCryst Pharmaceuticals Third Quarter 2023 Earnings Call. [Operator Instructions] Please note, this event is being recorded.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q2 2023 Earnings Call Transcript
Operator: Good morning and welcome to the BioCryst Second Quarter 2023 Earnings Call. [Operator Instructions] Please note this event is being recorded.
5 Best Medical Stocks Under $10
In this piece, we will take a look at the five best medical stocks under $10.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2023 Earnings Call Transcript
Operator: Good morning and welcome to the BioCryst Q1 2023 Earnings Conference Call. Please note this event is being recorded.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2022 Earnings Call Transcript
Operator: Good morning and welcome to the BioCryst Fourth Quarter 2022 Earnings Conference Call. Please note this event is being recorded.
5 Best Buy-the-Dip Stocks To Buy Now
In this article, we will take a look at the 5 best buy-the-dip stocks to buy now.
5 Best Small-Cap Healthcare Stocks To Buy Now
In this article, we discuss 5 best small-cap healthcare stocks to buy now.
Ken Fisher Super Stocks: 5 Biggest Small-Cap Stocks
In this article, we discuss the 5 biggest small-cap stocks in the Ken Fisher portfolio.
5 Small-Cap Stocks to Buy According to Ken Fisher
In this article, we discuss 5 small-cap stocks to buy according to Ken Fisher.
Analysts Are Downgrading These 10 Pharmaceutical Stocks
In this article, we present the 10 pharmaceutical stocks that are being downgraded by analysts.
10 Biotech Stocks to Buy Today According to Ken Fisher
In this piece, we will take a look at the ten biotechnology stocks to buy according to Ken Fisher's Fisher Asset Management.
Do Hedge Funds Love BioCryst Pharmaceuticals, Inc. (BCRX)?
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
15 Good Stocks to Buy Right Now
Investors are practicing extreme caution amid uncertainty caused by the resurgence of COVID-19 all over the world.
5 Biotech Stocks Popular On Reddit
In this article, we discuss the 5 biotech stocks popular on Reddit.
Is BioCryst Pharmaceuticals, Inc. (BCRX) Going to Burn These Hedge Funds?
A whopping number of 13F filings filed with U.S.
Billionaire Steve Cohen’s Top 10 Small-Cap Stock Picks
In this article we presented billionaire Steve Cohen's top 10 small-cap stock picks.
Billionaire Steve Cohen’s Top 5 Small-Cap Stock Picks
In this article we discuss the billionaire Steve Cohen's top 5 small-cap stock picks.
Is BCRX Stock A Buy or Sell?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market...
10 Best Small-Cap Biotech Stocks Under $10 in 2021
We like healthcare and technology industries because of their above-average long-term growth prospects. Biotechnology is at the intersection of healthcare and technology.
Is BCRX A Good Stock To Buy Now According To Hedge Funds?
In this article we will take a look at whether hedge funds think BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is a good investment right now.
Hedge Funds Keep Buying BioCryst Pharmaceuticals, Inc. (BCRX)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Did Hedge Funds Make The Right Call On BioCryst Pharmaceuticals, Inc. (BCRX) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Have Never Been This Bullish On BioCryst Pharmaceuticals, Inc. (BCRX)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Here is What Hedge Funds Think About BioCryst Pharmaceuticals, Inc. (BCRX)
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
BioCryst Pharmaceuticals, Inc. (BCRX) Are Selling These Hedge Funds
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.
Is BioCryst Pharmaceuticals, Inc. (BCRX) A Good Stock To Buy?
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Here’s What Hedge Funds Think About BioCryst Pharmaceuticals, Inc. (BCRX)
Is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
BioCryst Pharmaceuticals, Inc. (BCRX) Hedge Funds Are Snapping Up
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
13D Filing: RA Capital Management and Biocryst Pharmaceuticals Inc (BCRX)
Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...
13G Filing: James E. Flynn and Biocryst Pharmaceuticals Inc (BCRX)
You can access the original SEC filing by clicking here.
33 Fresh Stories From The World Of Finance Today
"World stock markets scaled fresh highs on Thursday, with key U.S. indexes lifted by rosy retailer results, while the U.S.
13G Filing: James E. Flynn and Biocryst Pharmaceuticals Inc (BCRX)
You can access the original SEC filing by clicking here.
BioCryst Pharmaceuticals, Inc. (BCRX): A Discount Entry?
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has caught our attention in the biotech space as being a company that has had a bit of a strange start to the week.
What Smart Money Thinks about BioCryst Pharmaceuticals, Inc. (BCRX)?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Biocryst Pharmaceuticals Inc (BCRX): Baker Bros. Advisors Unloads Nearly 4 Million Shares
Julian Baker and Felix Baker's Baker Bros.
Most Popular Healthcare Stocks Under $5
Most securities that cost less than a dinner at a fast-food restaurant are considered to be too risky, with most intra-day traders or other investors usually avoiding these low...
